[Tauroline in peritonitis].
D000818:Animals; D000900:Anti-Bacterial Agents; D000890:Anti-Infective Agents / Q000627:therapeutic use*; D001419:Bacteria / Q000187:drug effects; D001711:Biotransformation; D002986:Clinical Trials as Topic; D004341:Drug Evaluation; D005658:Fungi / Q000187:drug effects; D006207:Half-Life; D006801:Humans; D051379:Mice; D010538:Peritonitis / Q000188:drug therapy*; D011817:Rabbits; D051381:Rats; D013654:Taurine / Q000378:metabolism / Q000494:pharmacology / Q000627:therapeutic use*; D013829:Thiadiazines / Q000378:metabolism / Q000494:pharmacology / Q000627:therapeutic use*; D013843:Thiazines / Q000627:therapeutic use*
D000900:Anti-Bacterial Agents; D000890:Anti-Infective Agents; D013829:Thiadiazines; D013843:Thiazines; D013654:Taurine
Taurolin bei Peritonitis.